Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01980901
Other study ID # 771-0010
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 2013
Est. completion date September 1, 2020

Study information

Verified date June 2021
Source Endologix
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The Post-Approval Study (PAS) will evaluate the "real world" data on the Ovation™/Ovation Prime™ Abdominal Stent Graft System along with the long-term data collected from the IDE cohort to monitor the long-term safety and effectiveness of the device.


Description:

The purpose of the study is to demonstrate the long term safety and effectiveness of the Ovation™/Ovation Prime™ Abdominal Stent Graft System for the endovascular treatment of infrarenal abdominal aortic aneurysms in a post-approval environment. The clinical objective of the study is to evaluate the long term safety and effectiveness of the Ovation™/Ovation Prime™ Abdominal Stent Graft System assessed at 5 years through freedom from Aneurysm-Related Mortality. Additionally, this study will evaluate the physician training program for modifications based on IDE and post-approval experience.


Recruitment information / eligibility

Status Completed
Enrollment 320
Est. completion date September 1, 2020
Est. primary completion date September 1, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Patient is > 18 years of age. 2. Patients who are male or non-pregnant female (females of child bearing potential must have a negative pregnancy test prior to enrollment into the study). 3. Patient has signed an Institutional Review Board (IRB) approved Informed Consent Form. 4. Patient is considered by the treating physician to be a candidate for elective open surgical repair of the AAA (i.e., category I, II, or III per American Society of Anesthesiology (ASA) classification; refer to Appendix III: ASA Classification System). ASA category IV patients may be enrolled provided their life expectancy is greater than 1 year. 5. Patient has an infrarenal abdominal aortic aneurysm that meets at least one of the following: - Abdominal aortic aneurysm >5.0 cm in diameter - Aneurysm has increased in size by 0.5 cm in last 6 months. - Maximum diameter of aneurysm exceeds 1.5 times the transverse dimension of an adjacent non-aneurysmal aortic segment 6. Patient has patent iliac or femoral arteries that allow endovascular access with the TriVascular Ovation/Ovation Prime Abdominal Stent Graft System. 7. Patient has a suitable non-aneurysmal proximal aortic neck length of = 7 mm inferior to the most distal renal artery ostium. 8. Patient has a suitable non-aneurysmal distal iliac artery length (seal zone) of =10 mm. The resultant repair should preserve patency in at least one hypogastric artery. 9. Patient has a suitable non-aneurysmal proximal aortic neck luminal diameter between 16 and 30 mm. 10. Patient has suitable non-aneurysmal distal iliac luminal diameters between 8 and 20 mm. 11. Patient meets the following anatomic criteria: the distance from the most distal renal artery to most superior internal iliac artery measurement is at least 13 cm. 12. Patient has juxtarenal aortic neck angulation = 60º if proximal neck is =10 mm and = 45º if proximal neck is <10 mm. Patient must be willing to comply with all required follow-up exams. 13. Patient must be willing to comply with all required follow-up exams. Exclusion Criteria: 1. Patient has a dissecting aneurysm. 2. Patient has an acutely ruptured aneurysm. 3. Patient has an acute vascular injury. 4. Patient has a need for emergent surgery. 5. Patient has a known thoracic aortic aneurysm or dissection. 6. Patient has a mycotic aneurysm or has an active systemic infection. 7. Patient has unstable angina (defined as angina with a progressive increase in symptoms, new onset at rest or nocturnal angina, or onset of prolonged angina). 8. Patient has had a myocardial infarction (MI) and/or stroke (CVA) within the past 6 months. 9. Patient has a major surgical or interventional procedure planned =30 days of the AAA repair. 10. Patient has history of connective tissue disease (e.g., Marfan's or Ehler's-Danlos syndrome). 11. Patient has history of bleeding disorders or refuses blood transfusions. 12. Patient has dialysis dependent renal failure or baseline serum creatinine level >2.0 mg/dl 13. Patient has a known hypersensitivity or contraindication to anticoagulation or contrast media that is not amenable to pre-treatment. 14. Patient has a known allergy or intolerance to polytetrafluoroethylene (PTFE), PEG-based polymers, fluorinated ethylene propylene (FEP) or nitinol. 15. Patient has a body habitus that would inhibit X-ray visualization of the aorta 16. Patient has a limited life expectancy of less than 1 year 17. Patient is currently participating in an investigational device or drug clinical trial. 18. Patient has other medical, social or psychological conditions that, in the opinion of the investigator, preclude them from receiving the pre-treatment, required treatment, and post-treatment procedures and evaluations.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Ovation™/Ovation Prime™ Abdominal Stent Graft System
Single occurence permanent implant of AAA device.

Locations

Country Name City State
United States Christie Clinical Vein and Vascular Center Champaign Illinois

Sponsors (1)

Lead Sponsor Collaborator
TriVascular, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Freedom From Aneurysm-Related Mortality at 5 Years The primary endpoint of the Ovation™/Ovation Prime™ Abdominal Stent Graft System study will be determined by evaluating freedom from aneurysm-related mortality at five (5) years. This will be compared to a target performance goal. 5 Years
Secondary Composite Safety and Performance Endpoints Serious Adverse Events (SAEs) within 30 days of the initial procedure and through 12 months and annually thereafter to 5 years
At 30 days and 12 months and annually thereafter to 5 years, the following rates will be reported:
Mortality (AAA-related and all-cause)
Device patency
Conversion to open surgical repair
Endoleak
AAA enlargement
Stent Graft Migration
Device integrity
Secondary endovascular procedures
Aneurysm rupture
1 Month & Annually 1 to 5 Years
See also
  Status Clinical Trial Phase
Completed NCT03657979 - TAP-Block in Abdominal Aortic Surgery Phase 4
Enrolling by invitation NCT01465425 - Extracolonic Findings on Computed Tomography (CT) Colonography
Completed NCT02845167 - Effect of Preoperative Exercise on Postoperative Outcome in AAA Patients: Pilot Study N/A
Not yet recruiting NCT00358085 - NExT ERA: National Expertise Based Trial of Elective Repair of Abdominal Aortic Aneurysms: A Pilot Study Phase 3
Terminated NCT00118573 - Comparison of Surveillance Versus Aortic Endografting for Small Aneurysm Repair Phase 4
Completed NCT04792411 - Adherence and Acceptability of a Remote, Home-based, Pre-surgery Programme for Patients Undergoing Abdominal Aortic Aneurysm Surgery N/A
Completed NCT04930172 - TOtal tRansfemoral branCHed endovasCular tHoracoabdominal Aortic Repair Registry
Withdrawn NCT02995642 - Targeted PET/CT and PET/MRI Imaging of Vascular Inflammation Phase 2
Active, not recruiting NCT01698671 - InterGard Synergy Post-Marketing Surveillance Study N/A
Enrolling by invitation NCT00831870 - EndoSure Sensor for Long-term Follow-up After Endovascular AAA Repair N/A
Recruiting NCT05972018 - Liposomal Bupivacaine/Bupivacaine in RS Blocks vs. Ropivacaine in RS Blocks And Catheters Phase 4
Not yet recruiting NCT02997618 - The AAA Get Fit Trial: A Pilot Randomised Controlled Trial of Community Based Exercise in Patients With Abdominal Aortic Aneurysms N/A
Active, not recruiting NCT02907762 - Aorfix Intelliflex First in Human Study
Completed NCT00349947 - Exercise Therapy to Treat Adults With Abdominal Aortic Aneurysms Phase 1
Completed NCT04080557 - Abdominal Aortic Aneurysm Patients Remain at Risk for Delirium on the Surgical Ward After Intensive Care Unit Dismissal
Recruiting NCT05484115 - Comparison of EVAR and ESAR for Infrarenal Aortic Aneurysms With a Wide Proximal Neck N/A
Recruiting NCT04503395 - ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES N/A
Completed NCT02867501 - Venous Distension in Patients With Aneurysmatic Arterial Disease N/A
Recruiting NCT02345590 - Eplerenone in the Management of Abdominal Aortic Aneurysms Phase 4
Recruiting NCT01985906 - Safety and Efficacy of Multiple Overlapping Uncovered Stents for Pararenal Aortic Aneurysm Repair N/A